Events2Join

Bayer and Broad Institute extend cancer therapy research ...


Bayer and Broad Institute extend cancer therapy research ...

Established in 2013, the Bayer-Broad collaboration is uniquely structured to encourage close coordination and ongoing, face-to-face interactions ...

Bayer Extends Research Collaboration for Cancer Therapies

Berlin, Germany and Cambridge, MA, USA, November 2, 2023 – Bayer and the Broad Institute of MIT and Harvard today announced that they have ...

Bayer and Broad Institute of MIT and Harvard extend research ...

Agreement to focus on joint cancer target identification and discovery of new therapeutic approaches / Extended collaboration strengthens ...

Bayer, Broad expand partnership to advance cancer drug discovery ...

Bayer and the Broad Institute of MIT and Harvard announced today that they have extended their multi-disciplinary research partnership by an additional five ...

Bayer and Broad Institute of MIT and Harvard Extend Research ...

BERLIN & CAMBRIDGE, Mass., November 02, 2023--Bayer and the Broad Institute of MIT and Harvard today announced that they have extended their ...

Q&A: New approaches are needed to find better cancer drug targets

Bayer and Broad Institute extend cancer therapy research collaboration · Read more · Hakimeh Ebrahimi-Nik prepares samples in the lab. News ...

Bayer, Broad Institute extend cancer therapies development

Bayer and the Broad Institute of MIT and Harvard have expanded their ten-year research partnership to further develop cancer treatments.

Bayer and Broad Institute extend cancer therapy research ...

"Bayer's established collaboration with the Broad Institute has already resulted in three clinical oncology candidates over the past decade. We ...

Bayer and Broad Institute of MIT and Harvard Extend Research ...

Agreement to focus on joint cancer target identification and discovery of new therapeutic approaches · Extended collaboration strengthens Bayer's precision ...

Targeted drug treatment leads tumor cells to imitate viral infection

Bayer and Broad Institute extend cancer therapy research collaboration · Read more · Hakimeh Ebrahimi-Nik prepares samples in the lab. News ...

Bayer and Broad Institute extend longstanding cancer research ...

The expanded agreement will focus on joint cancer target identification and discovery of new therapeutic approaches in oncology. Broad ...

Cancer | Broad Institute

Broad cancer research includes efforts to decipher the genetic and molecular landscape of a wide range of cancer and immune cells as well as equally ...

Bayer, Broad Institute Of MIT, Harvard Extend Oncology Alliance

... research for novel cancer treatments. Both parties will continue their work on identifying additional investigational drugs for new oncology ...

Broad and Bayer expand partnership, launching new research effort ...

The Broad Institute of MIT and Harvard and Bayer are launching the Precision Cardiology Laboratory, a new endeavor that will pursue scientific ...

Bayer and Broad Institute Extend Cancer Therapy Research ...

Bayer and the Broad Institute of MIT and Harvard renewed their research alliance, adding 5 years to a 10-year collaboration that yielded three clinical oncology ...

Bayer and the Broad Institute of MIT and Harvard Expand ...

... Expand Partnership to Advance Drug Discovery Research for Novel Cancer Treatments ... Broad Institute's expertise in cancer research and ...

A research team searches for every gene that helps tumors evade ...

Bayer and Broad Institute extend cancer therapy research collaboration · Read more · Model of a normal dendritic cell, a kind of immune cell ...

Bayer extends research collaboration for cancer treatments

Bayer has extended its ongoing research collaboration with the Broad Institute of MIT and Harvard in the US by five years for the ...

Broad Institute and Bayer join forces to develop novel treatment ...

The goal of oncogenomics research is to identify new genes which, when mutated, stimulate or lose the ability to suppress tumor cell growth.

Bayer, Broad Institute extend cancer therapy research collaboration

Cambridge: Bayer and the Broad Institute of MIT and Harvard have renewed their research alliance, adding five years to a 10-year ...